| Dr Susan M Emmerling, MD | |
|
9000 N Main St, Suite 232, Dayton, OH 45415 | |
| (937) 277-8988 | |
| (937) 274-4293 |
| Full Name | Dr Susan M Emmerling |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 9000 N Main St, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013229061 | NPI | - | NPPES |
| 0105039 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35123733 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Miami Valley Hospital | Dayton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Specialists Inc | 5597708594 | 394 |
News Archive
Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.
Chronic cough – often causing much discomfort, frustration, irritability and sleep disturbances in 10 percent to 20 percent of adults – is one of the leading reasons for consultation with a physician according to a report published this month in Annals of Allergy, Asthma & Immunology , the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 5 days ago
| Entity Name | Premier Health Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194958223 PECOS PAC ID: 5597708594 Enrollment ID: O20050610000010 |
News Archive
Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.
Chronic cough – often causing much discomfort, frustration, irritability and sleep disturbances in 10 percent to 20 percent of adults – is one of the leading reasons for consultation with a physician according to a report published this month in Annals of Allergy, Asthma & Immunology , the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan M Emmerling, MD 3130 Kettering Blvd Bldg B, Moraine, OH 45439-1924 Ph: (937) 991-3188 | Dr Susan M Emmerling, MD 9000 N Main St, Suite 232, Dayton, OH 45415 Ph: (937) 277-8988 |
News Archive
Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.
Chronic cough – often causing much discomfort, frustration, irritability and sleep disturbances in 10 percent to 20 percent of adults – is one of the leading reasons for consultation with a physician according to a report published this month in Annals of Allergy, Asthma & Immunology , the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.
With the health law repeal front and center this week, Democrats will attempt to refine their message on the measure's merits. The battle on the House floor could be a fresh opportunity to sell the sweeping legislation. To this end, the Secretary of Health and Human Services will issue a report today that quantifies the number of Americans who have preexisting conditions and would benefit from the law's protections.
› Verified 5 days ago
Jiri David Sonek, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Berry Bldg, Ground Fl, Dayton, OH 45409 Phone: 937-208-2516 Fax: 937-208-6124 | |
Nancy G Romer, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Wyoming St, Ste. 4140, Dayton, OH 45409 Phone: 937-208-4110 Fax: 937-208-6260 | |
Samantha Elizabeth Houser, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5701 Far Hills Ave, Dayton, OH 45429 Phone: 937-435-6222 | |
Sheela M Barhan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Suite 4130, Dayton, OH 45409 Phone: 937-208-6810 | |
Dr. Geoffrey David Towers, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Suite 4130, Dayton, OH 45409 Phone: 937-208-6810 Fax: 937-222-7255 | |
Dr. Andre Todd Harris Sr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Elizabeth Pl, 5th Flr, Ste. M, Dayton, OH 45417 Phone: 937-228-4942 |